Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52

D-0550-2023

March 16, 2023

Class II

Product summary

Firm
Northwind Pharmaceuticals LLC
Event
Event 91944
Status
Ongoing
Classification
Class II
Quantity
33 bottles
Official record key
drug-enforcement:D-0550-2023

Official wording

Reason: CGMP Deviations

Code information: Lot#: F107752201, Exp. Date 05/31/2024

Distribution pattern: Nationwide with the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations